Cannabinoid medicine: Challenges for health care providers and its potential benefits for patients

Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, its challenges for health care providers and its potential benefits for patients.

In these important articles, University of Washington authors, Sunil Aggarwal, PhD who is a member of the prestigious Medical Scientist Training Program and who conducted the article's research and Gregory T. Carter, MD, nationally recognized expert in the field of pain management, lead their team in taking a fresh look at all aspects of cannabinoid medicines, including the cannabinoid botanical marijuana, from the historical perspective and clinical evidence base for its use to the legal ramifications. In the second article, they offer a chart review examination of the treatment with medical cannabis of 139 chronic pain patients in the state of Washington.

As the authors point out, there is a near complete absence of education about cannabinoid medicine at any level of medical training despite the fact the Institute of Medicine concluded, after reviewing relevant scientific literature including dozens of works documenting marijuana's therapeutic value, that nausea, appetite loss, pain, and anxiety are all afflictions of wasting and all can be mitigated by the drug safely and with minimal toxicity. The research also shows that cannabinoid medicines have particular application for patients intolerant or refractory of opioid therapies for pain management.

The authors conclude that while cannabis is neither a miracle drug nor the answer to everyone's ills, the evidence suggests that physicians and medical students should make an extra effort to educate themselves in the art and science of cannabinoid medicine.

To purchase a reprint of Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions Sunil K. Aggarwal, PhD; Gregory T. Carter, MD, MS; Mark D. Sullivan, MD, PhD; Craig ZumBrunnen, PhD; Richard Morrill, PhD; Jonathan D. Mayer, PhD click this link http://tinyurl.com/ydqwtd2

To purchase a reprint of Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State Sunil K. Aggarwal, PhD, MD Candidate; Gregory T. Carter, MD, MS; Mark D. Sullivan, MD, PhD; Craig ZumBrunnen, PhD; Richard Morrill, PhD; Jonathan D. Mayer, PhD click this link http://tinyurl.com/y9yk9zq .

Journal of Opioid Management, a professional, peer-reviewed publication is designed to meet the challenge faced by physicians as they prescribe powerful, quality-of-life enhancing painkillers to their patients. Filling a long standing gap in medical literature, it addresses all aspects of opioid use and safe management and does so at a time when the federal spotlight has been switched on to the rising problem of abuse and addiction tied to these prescription painkillers.

Source:

Journal of Opioid Management

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Genetic variant increases risk of addiction in the presence of childhood stress